Oblique Therapeutics: Funding, Investors & Team (Sep 2026)
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
Oblique Therapeutics has raised $1.4M across 1 funding round on record, the most recent an undisclosed round of $1.4M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oblique Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Oblique Therapeutics Funding Rounds
Oblique Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Oblique Therapeutics Funding Compared to Other Biotechnology Startups
Oblique Therapeutics' latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oblique Therapeutics in Biotechnology and Göteborg
Companies Similar to Oblique Therapeutics
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D…
Oblique Therapeutics Funding FAQs
What does Oblique Therapeutics do?
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
How much funding has Oblique Therapeutics raised?
Oblique Therapeutics has raised $1.4M across 1 round on record. The most recent is an undisclosed round of $1.4M announced in Jun 2026.
When did Oblique Therapeutics last raise funding?
Oblique Therapeutics' most recent funding round on record is an undisclosed round of $1.4M, announced in Jun 2026.
Who founded Oblique Therapeutics?
FundedIQ lists Christer Nordstedt (Founder) at Oblique Therapeutics.
Where is Oblique Therapeutics headquartered?
Oblique Therapeutics is based in Göteborg, Vastra Gotaland, Sweden.
How many employees does Oblique Therapeutics have?
Oblique Therapeutics is in the 1-10 employee band.
How does Oblique Therapeutics' funding compare to other Biotechnology startups?
Oblique Therapeutics' latest round of $1.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Oblique Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oblique Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.